| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |